Orphazyme (ORPH) Stock Soars 50% This Week: How far Can it Go?
Biopharmaceutical firm Orphazyme (NASDAQ:ORPH) has emerged as a major gainer over the course of the past two days and in the past two trading sessions the stock has managed to clock gains of 50%. ‘ In light of the sort of gains recorded by the stock in the past two sessions, it could be a good time for investors to look into it a bit more closely. There has been…